Literature DB >> 27663885

miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.

Gang Peng1, Yiwei Liao1, Chenfu Shen2.   

Abstract

Glioblastoma multiforme (GBM), the most common primary brain cancer in adults, is usually the most lethal type of brain tumor. MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that deeply involves with the regulation of gene expression and cellular processes, including proliferation, apoptosis, migration and invasion. The objective of the study is to investigate the effect of miRNA-429 on human glioblastoma tissues and cell lines. miRNA-429 expressions in human glioblastoma, normal brain tissue samples, and human malignant glioma cell lines (U87, U251 and LN229) were compared using reverse transcription-quantitative PCR and western blot methods. U251 cell lines were transfected with miRNA-429 mimics, and then the effects of miRNA-429 on cell proliferation and invasion were investigated by CCK8 and Transwell invasion assay, respectively. It was found that miRNA-429 expression was significantly reduced in the examined Glioblastoma samples and human glioma cell lines. Overexpression of miRNA-429 inhibited Glioblastoma cell proliferation and invasion. Additionally, the present study also showed that BMI1 was a functional target of miRNA-429. Overexpression of BMI1 undermined the inhibition effect of miRNA-429 in glioblastoma and U251 cell lines. The current study demonstrated that miRNA-429, as a tumor suppressor gene, was capable of negatively regulating the expression of BMI1 in U251 cells.

Entities:  

Keywords:  BMI1; Glioblastoma; Invasion; Proliferation; miRNA-429

Mesh:

Substances:

Year:  2016        PMID: 27663885     DOI: 10.1007/s12253-016-0113-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

Review 1.  Targeting the p53 pathway of apoptosis.

Authors:  Joana D Amaral; Joana M Xavier; Clifford J Steer; Cecília M P Rodrigues
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 2.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

3.  Tumor-suppressing effects of miR-429 on human osteosarcoma.

Authors:  Xiaozhou Liu; Yunlai Liu; Sujia Wu; Xin Shi; Lihong Li; Jianning Zhao; Haidong Xu
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

4.  MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2.

Authors:  Ping Zhu; Jingping Zhang; Jianfei Zhu; Jun Shi; Qiuwei Zhu; Yuanyuan Gao
Journal:  Cell Physiol Biochem       Date:  2015-10-30

5.  MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.

Authors:  Xiangyang Tian; Zibai Wei; Jia Wang; Ping Liu; Yijun Qin; Meizuo Zhong
Journal:  Oncol Rep       Date:  2015-06-08       Impact factor: 3.906

6.  Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.

Authors:  Yongri Ouyang; Ping Gao; Baoyi Zhu; Xi Chen; Fang Lin; Xi Wang; Junxia Wei; Huizhong Zhang
Journal:  Mol Med Rep       Date:  2014-10-27       Impact factor: 2.952

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.

Authors:  Gang Peng; Xianrui Yuan; Jian Yuan; Qing Liu; Minhui Dai; Chenfu Shen; Jianrong Ma; Yiwei Liao; Weixi Jiang
Journal:  Mol Cell Biochem       Date:  2015-07-26       Impact factor: 3.396

9.  MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1.

Authors:  Wanke Lei; Yun-e Liu; Yuzhu Zheng; Lin Qu
Journal:  Med Sci Monit       Date:  2015-02-02

10.  miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.

Authors:  Min Zhang; Bing-Bin Dong; Min Lu; Mei-Juan Zheng; He Chen; Jing-Zhen Ding; A-Man Xu; Yuan-Hong Xu
Journal:  Onco Targets Ther       Date:  2016-03-03       Impact factor: 4.147

View more
  4 in total

1.  PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients.

Authors:  Chengmin Xuan; Mingwei Jin; Lei Wang; Shengbai Xue; Qi An; Qingzeng Sun; Lei Wang; Yong Gao
Journal:  Biomed Res Int       Date:  2020-04-13       Impact factor: 3.411

2.  Regulatory networks between Polycomb complexes and non-coding RNAs in the central nervous system.

Authors:  Ya-Jie Xu; Pei-Pei Liu; Shyh-Chang Ng; Zhao-Qian Teng; Chang-Mei Liu
Journal:  J Mol Cell Biol       Date:  2020-06-11       Impact factor: 6.216

3.  The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients.

Authors:  Siwei Zhang; Wenxing Yue; Yan Xie; Lingzhi Liu; Shen Li; Wei Dang; Shuyu Xin; Li Yang; Xingyu Zhai; Pengfei Cao; Jianhong Lu
Journal:  Oncol Rep       Date:  2019-09-16       Impact factor: 3.906

4.  Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429.

Authors:  Yute Sun; Zuoqiong Hou; Binlin Luo; Chujun Li; Jinfang Liu; Jianlan Liu; Jian Tang; Gang Yao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.